Nanoparticles for combination drug therapy

ACS Nano

Volumn 7, Issue 11, 2013, Pages 9518-9525

  Ma, Liang ^a   Kohli, Manish ^b   Smith, Andrew ^a  

^a University of Illinois at Urbana Champaign   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODELS OF DISEASE; CLINICAL PRACTICES; CLINICAL TRANSLATION; CO DELIVERIES; COMBINATION THERAPY; DRUG RELEASE; SCREENING TOOL; SMALL-MOLECULE DRUGS;

DIAGNOSIS; NANOPARTICLES;

DRUG THERAPY;

DRUG CARRIER; NANOPARTICLE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CHEMISTRY; DRUG COMBINATION; DRUG SCREENING; HUMAN; MEDICINAL CHEMISTRY; METHODOLOGY; MOUSE; NANOMEDICINE; NEOPLASM; SYSTEMS BIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG THERAPY, COMBINATION; HUMANS; MICE; NANOMEDICINE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; NEOPLASMS; SYSTEMS BIOLOGY;

EID: 84888883621     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn405674m     Document Type: Review

References (36)

1. Woodcock, J.; Griffin, J. P.; Behrman, R. E. Development of Novel Combination Therapies N. Engl. J. Med. 2011, 364, 985-987
2. Wang, A. Z.; Langer, R.; Farokhzad, O. C. Nanoparticle Delivery of Cancer Drugs Annu. Rev. Med. 2012, 63, 185-198
3. Al-Lazikani, B.; Banerji, U.; Workman, P. Combinatorial Drug Therapy for Cancer in the Post-Genomic Era Nat. Biotechnol. 2012, 30, 1-13
4. Batist, G.; Gelmon, K. A.; Chi, K. N.; Miller, W. H.; Chia, S. K. L.; Mayer, L. D.; Swenson, C. E.; Janoff, A. S.; Louie, A. C. Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors Clin. Cancer Res. 2009, 15, 692-700
5. Tardi, P.; Johnstone, S.; Harasyrn, N.; Xie, S. W.; Harasyrn, T.; Zisman, N.; Harvie, P.; Bermudes, D.; Mayer, L. In Vivo Maintenance of Synergistic Cytarabine:Daunorubicin Ratios Greatly Enhances Therapeutic Efficacy Leuk. Res. 2009, 33, 129-139
6. Katragadda, U.; Fan, W.; Wang, Y. Z.; Teng, Q.; Tan, C. Combined Delivery of Paclitaxel and Tanespimycin via Micellar Nanocarriers: Pharmacokinetics, Efficacy and Metabolomic Analysis PLoS One 2013, 8, e58619
7. Hrkach, J.; Von Hoff, D.; Ali, M. M.; Andrianova, E.; Auer, J.; Campbell, T.; De Witt, D.; Figa, M.; Figueiredo, M.; Horhota, A. et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Sci. Transl. Med. 2012, 4, 128ra39
8. Kolishetti, N.; Dhar, S.; Valencia, P. M.; Lin, L. Q.; Karnik, R.; Lippard, S. J.; Langer, R.; Farokhzad, O. C. Engineering of Self-Assembled Nanoparticle Platform for Precisely Controlled Combination Drug Therapy Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 17939-17944
9. Park, J.; Wrzesinski, S. H.; Stern, E.; Look, M.; Criscione, J.; Ragheb, R.; Jay, S. M.; Demento, S. L.; Agawu, A.; Limon, P. L. et al. Combination Delivery of TGF-Beta Inhibitor and IL-2 by Nanoscale Liposomal Polymeric Gels Enhances Tumour Immunotherapy Nat. Mater. 2012, 11, 895-905
10. Mitragotri, S.; Barua, S. Synergistic Targeting of Cell Membrane, Cytoplasm, and Nucleus of Cancer Cells Using Rod-Shaped Nanoparticles ACS Nano 2013, 10.1021/nn403913k
11. Choi, H. S.; Liu, W.; Liu, F.; Nasr, K.; Misra, P.; Bawendi, M.; Frangioni, J. V. Design Considerations for Tumor-Targeted Nanoparticles Nat. Nanotechnol. 2010, 5, 42-47
12. Tang, L.; Fan, T. M.; Borst, L. B.; Cheng, J. J. Synthesis and Biological Response of Size-Specific, Monodisperse Drug-Silica Nanoconjugates ACS Nano 2012, 6, 3954-3966
13. Meng, H. A.; Liong, M.; Xia, T. A.; Li, Z. X.; Ji, Z. X.; Zink, J. I.; Nel, A. E. Engineered Design of Mesoporous Silica Nanoparticles To Deliver Doxorubicin and P-Glycoprotein siRNA To Overcome Drug Resistance in a Cancer Cell Line ACS Nano 2010, 4, 4539-4550
14. Ashley, C. E.; Carnes, E. C.; Phillips, G. K.; Padilla, D.; Durfee, P. N.; Brown, P. A.; Hanna, T. N.; Liu, J. W.; Phillips, B.; Carter, M. B. et al. The Targeted Delivery of Multicomponent Cargos to Cancer Cells by Nanoporous Particle-Supported Lipid Bilayers Nat. Mater. 2011, 10, 389-397
15. Chou, T. C.; Talalay, P. Quantitative Analysis of Dose-Effect Relationships: The Combined Effects of Multiple Drugs or Enzyme Inhibitors Adv. Enzyme Regul. 1984, 22, 27-55
16. Yeh, P. J.; Hegreness, M. J.; Aiden, A. P.; Kishony, R. Drug Interactions and the Evolution of Antibiotic Resistance Nat. Rev. Microbiol. 2009, 7, 460-466
17. Lehar, J.; Krueger, A. S.; Avery, W.; Heilbut, A. M.; Johansen, L. M.; Price, E. R.; Rickles, R. J.; Short, G. F.; Staunton, J. E.; Jin, X. W. et al. Synergistic Drug Combinations Tend To Improve Therapeutically Relevant Selectivity Nat. Biotechnol. 2009, 27, 659-666
18. Shi, J. J.; Xiao, Z. Y.; Kamaly, N.; Farokhzad, O. C. Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation Acc. Chem. Res. 2011, 44, 1123-1134
19. Cokol, M.; Chua, H. N.; Tasan, M.; Mutlu, B.; Weinstein, Z. B.; Suzuki, Y.; Nergiz, M. E.; Costanzo, M.; Baryshnikova, A.; Giaever, G. et al. Systematic Exploration of Synergistic Drug Pairs Mol. Syst. Biol. 2011, 7, 544
20. Jia, J.; Zhu, F.; Ma, X. H.; Cao, Z. W. W.; Li, Y. X. X.; Chen, Y. Z. Mechanisms of Drug Combinations: Interaction and Network Perspectives Nat. Rev. Drug Discovery 2009, 8, 111-128
21. Shi, Q. H.; Qin, L. D.; Wei, W.; Geng, F.; Fan, R.; Shin, Y. S.; Guo, D. L.; Hood, L.; Mischel, P. S.; Heath, J. R. Single-Cell Proteomic Chip for Profiling Intracellular Signaling Pathways in Single Tumor Cells Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 419-424
22. Wood, K. C.; Konieczkowski, D. J.; Johannessen, C. M.; Boehm, J. S.; Tamayo, P.; Botvinnik, O. B.; Mesirov, J. P.; Hahn, W. C.; Root, D. E.; Garraway, L. A. et al. MicroSCALE Screening Reveals Genetic Modifiers of Therapeutic Response in Melanoma Sci. Signaling 2012, 5, rs4
23. Wood, K.; Nishida, S.; Sontag, E. D.; Cluzel, P. Mechanism-Independent Method for Predicting Response to Multidrug Combinations in Bacteria Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 12254-12259
24. Zervantonakis, I. K.; Hughes-Alford, S. K.; Charest, J. L.; Condeelis, J. S.; Gertler, F. B.; Kamm, R. D. Three-Dimensional Microfluidic Model for Tumor Cell Intravasation and Endothelial Barrier Function Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 13515-13520
25. Goel, S.; Duda, D. G.; Xu, L.; Munn, L. L.; Boucher, Y.; Fukumura, D.; Jain, R. K. Normalization of the Vasculature for Treatment of Cancer and Other Diseases Physiol. Rev. 2011, 91, 1071-1121
26. Wei, W.; Shi, Q. H.; Remacle, F.; Qin, L. D.; Shackelford, D. B.; Shin, Y. S.; Mischel, P. S.; Levine, R. D.; Heath, J. R. Hypoxia Induces a Phase Transition within a Kinase Signaling Network in Cancer Cells Proc. Natl. Acad. Sci. U.S.A. 2013, 110, E1352-E1360
27. Roussos, E. T.; Condeelis, J. S.; Patsialou, A. Chemotaxis in Cancer Nat. Rev. Cancer 2011, 11, 573-587
28. Kopetz, S.; Lemos, R.; Powis, G. The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men Clin. Cancer Res. 2012, 18, 5160-5162
29. Olafsen, T.; Kenanova, V. E.; Sundaresan, G.; Anderson, A. L.; Crow, D.; Yazaki, P. J.; Li, L.; Press, M. F.; Williams, L. E.; Wong, J. Y. C. et al. Optimizing Radiolabeled Engineered Anti-p185(HER2) Antibody Fragments for In Vivo Imaging Cancer Res. 2005, 65, 5907-5916 (Pubitemid 40911197)
30. Schmidt, M. M.; Wittrup, K. D. A Modeling Analysis of the Effects of Molecular Size and Binding Affinity on Tumor Targeting Mol. Cancer Ther. 2009, 8, 2861-2871
31. Carver, L. A.; Schnitzer, J. E. Caveolae: Mining Little Caves for New Cancer Targets Nat. Rev. Cancer 2003, 3, 571-581 (Pubitemid 37328829)
32. Prabhakar, U.; Maeda, H.; Jain, R. K.; Sevick-Muraca, E. M.; Zamboni, W.; Farokhzad, O. C.; Barry, S. T.; Gabizon, A.; Grodzinski, P.; Blakey, D. C. Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology Cancer Res. 2013, 73, 2412-2417
33. Chrastina, A.; Massey, K. A.; Schnitzer, J. E. Overcoming In Vivo Barriers to Targeted Nanodelivery Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2011, 3, 421-437
34. Huang, X. H.; Peng, X. H.; Wang, Y. Q.; Wang, Y. X.; Shin, D. M.; El-Sayed, M. A.; Nie, S. M. A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands ACS Nano 2010, 4, 5887-5896
35. Joo, K. M.; Kim, J.; Jin, J.; Kim, M.; Seol, H. J.; Muradov, J.; Yang, H.; Choi, Y. L.; Park, W. Y.; Kong, D. S. et al. Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas in Situ Cell Rep. 2013, 3, 260-273
36. Lin, E. Y.; Jones, J. G.; Li, P.; Zhu, U. Y.; Whitney, K. D.; Muller, W. J.; Pollard, J. W. Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases Am. J. Pathol. 2003, 163, 2113-2126 (Pubitemid 37310040)